Spectrum of Hyperaldosteronism, Opportunities for Diagnosis
Primary aldosteronism (PA) is a common cause of secondary hypertension. It is characterized by renin-independent overproduction of aldosterone by the adrenal glands. Recent data indicate higher prevalence of PA than previously thought. The clinical presentation varies depending on the severity of aldosterone hypersecretion. Several studies suggest that PA manifests as a continuous spectrum. We present 2 clinical scenarios that highlight the challenges clinicians face while interpreting the biochemical work-up for PA. We emphasize the importance of understanding the pathophysiology of PA while interpreting borderline results. The aim is to underscore the importance of early recognition and treatment of PA, which can improve outcomes.
Authors
- Mohamad Anas Sukkari
- Gonzalo J. Acosta (ORCID: https://orcid.org/0000-0002-0521-3895)
- Hans K. Ghayee (ORCID: https://orcid.org/0000-0001-9201-3033)
- Jan Zeman (ORCID: https://orcid.org/0000-0002-8804-2672)
- Karel Pacák
Institutions
- National Institutes of Health (US)
- University of Connecticut (US)
- University of Florida (US)
- Malcom Randall VA Medical Center (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
Publication Details
- Journal
- Annals of Internal Medicine Clinical Cases
- Published
- 2024-11-01
- DOI
- https://doi.org/10.7326/aimcc.2024.0383
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00